IL37 and type 2 diabetes mellitus: Fig 8 showed that T2DM was associated with marked inflammatory events as evidenced by a 4.7-fold increment in the pro-inflammatory cytokine, IL-23 (A), and a 63.3% reduction in the anti-inflammatory cytokine, IL-27 (B) as compared to the NC group.